Pharmaceutical company Merck’s Global Health Innovation Fund (Merck GHI) invested an undisclosed amount in US-based data management company Liaison Technologies on Thursday, bringing its total funding to $90m.
Founded in 2000, Liaison’s cloud-based healthcare data management platform enables doctors to securely share, store and exchange patient data. The company has also adapted its software to the financial, logistics, retail and manufacturing sectors.
Merck GHI initially invested $30m in Liaison in 2012. According to regulatory filings, Liaison also raised $728,000 in 2013 and $15m in April 2014, indicating that Merck’s latest investment could be up to $44m in size.
The capital will be used to continue development of Liaison’s healthcare platform and to support growth through further acquisitions. Liaison acquired Intel-backed data management company Hubspan in 2012 for an undisclosed sum.
Joe Volpe, managing director of Merck GHI, said: “We are excited to continue supporting Liaison’s growing market leadership in cloud data innovation helping major healthcare companies transcend the enormity of challenges they face in streamlining data.”